FR2813530B1 - Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures - Google Patents

Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures

Info

Publication number
FR2813530B1
FR2813530B1 FR0111126A FR0111126A FR2813530B1 FR 2813530 B1 FR2813530 B1 FR 2813530B1 FR 0111126 A FR0111126 A FR 0111126A FR 0111126 A FR0111126 A FR 0111126A FR 2813530 B1 FR2813530 B1 FR 2813530B1
Authority
FR
France
Prior art keywords
diclofenac
manufacture
treating burns
topical medicine
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0111126A
Other languages
English (en)
French (fr)
Other versions
FR2813530A1 (fr
Inventor
Dominique Sallin
Jean Luc Kienzler
Phyllis Schumann
Jacek Ancerewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haleon CH SARL
Original Assignee
Haleon CH SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haleon CH SARL filed Critical Haleon CH SARL
Publication of FR2813530A1 publication Critical patent/FR2813530A1/fr
Application granted granted Critical
Publication of FR2813530B1 publication Critical patent/FR2813530B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polarising Elements (AREA)
  • Magnetic Heads (AREA)
  • Semiconductor Lasers (AREA)
FR0111126A 2000-09-01 2001-08-27 Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures Expired - Fee Related FR2813530B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00118968 2000-09-01

Publications (2)

Publication Number Publication Date
FR2813530A1 FR2813530A1 (fr) 2002-03-08
FR2813530B1 true FR2813530B1 (fr) 2005-05-20

Family

ID=8169725

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111126A Expired - Fee Related FR2813530B1 (fr) 2000-09-01 2001-08-27 Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures

Country Status (31)

Country Link
US (1) US20030187069A1 (enExample)
JP (1) JP2004507497A (enExample)
KR (1) KR100880056B1 (enExample)
CN (1) CN100350905C (enExample)
AR (1) AR030522A1 (enExample)
AT (1) AT504040B1 (enExample)
AU (2) AU2001287706B2 (enExample)
BE (1) BE1014352A5 (enExample)
CA (1) CA2414921C (enExample)
CH (1) CH695416A5 (enExample)
CZ (1) CZ303849B6 (enExample)
DE (2) DE10196483T1 (enExample)
DK (1) DK200300274A (enExample)
ES (1) ES2201941B1 (enExample)
FI (1) FI119840B (enExample)
FR (1) FR2813530B1 (enExample)
GB (1) GB2381455B (enExample)
GR (1) GR1004434B (enExample)
HU (1) HU230783B1 (enExample)
IL (2) IL153816A0 (enExample)
IT (1) ITMI20011820A1 (enExample)
LU (1) LU91009B1 (enExample)
MX (1) MXPA03001830A (enExample)
NL (1) NL1018862C2 (enExample)
NO (1) NO330590B1 (enExample)
PL (1) PL359807A1 (enExample)
RU (1) RU2314802C2 (enExample)
SE (1) SE527137C2 (enExample)
TW (1) TWI290464B (enExample)
WO (1) WO2002017905A2 (enExample)
ZA (1) ZA200300284B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
CN105395544A (zh) * 2014-08-23 2016-03-16 南京海纳医药科技有限公司 双氯芬酸依泊胺凝胶制备方法及药物用途
WO2016038553A1 (en) 2014-09-10 2016-03-17 Novartis Consumer Health S.A. Topical diclofenac sodium compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
DE8210781U1 (de) * 1982-04-16 1982-06-24 Unilever N.V., 3000 Rotterdam Staubdichte Faltschachtel
CH655656B (enExample) * 1982-10-07 1986-05-15
JPS59170011A (ja) * 1983-03-16 1984-09-26 Pola Chem Ind Inc 日焼け防止化粧料
DE3707532C2 (de) 1987-03-09 1998-05-28 Bauer Johann Verwendung einer Kombination von Extr. Gingko biloba oder mindestens einem Gingkolid und Acetylsalicylsäure oder DL-Lysin-mono-acetylsalicylat oder Diflunisal zur Behandlung von Verbrennungen, Verbrühungen, Strahlenschäden und Erfrierungen
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
IT1229489B (it) 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
RU2008002C1 (ru) * 1989-03-23 1994-02-28 Центр по химии лекарственных средств Противовоспалительный состав и способ его получения
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
JP3526887B2 (ja) 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
JP2000500449A (ja) * 1995-11-13 2000-01-18 ピットミー・インターナショナル・ナムローゼ・フェンノートシャップ 一酸化二窒素を含む鎮痛剤、抗炎症剤、および抗発熱剤のための投与媒体とそれらの医薬組成物
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
EP0923937B1 (en) * 1997-12-08 2004-03-10 Council of Scientific and Industrial Research A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders
DE19844116A1 (de) 1998-08-06 2000-02-24 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur Prophylaxe und Therapie von ischämischen Organschäden und Reperfusionssyndromen
RU2140258C1 (ru) * 1999-03-17 1999-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Гидрофильная фармацевтическая композиция, обладающая противовоспалительным действием
WO2000072883A2 (en) * 1999-06-02 2000-12-07 Aviana Biopharm Pharmaceutical transdermal compositions
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10025328A1 (de) * 2000-05-23 2001-12-06 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen

Also Published As

Publication number Publication date
WO2002017905A3 (en) 2002-05-16
KR20030027100A (ko) 2003-04-03
GB2381455A (en) 2003-05-07
IL153816A0 (en) 2003-07-31
NO20030767D0 (no) 2003-02-18
IL153816A (en) 2011-07-31
NO20030767L (no) 2003-02-18
ITMI20011820A1 (it) 2003-02-28
ES2201941B1 (es) 2005-06-01
AR030522A1 (es) 2003-08-20
GR20010100390A (el) 2002-07-31
WO2002017905A2 (en) 2002-03-07
SE0300535L (sv) 2003-04-29
AU8770601A (en) 2002-03-13
NO330590B1 (no) 2011-05-23
JP2004507497A (ja) 2004-03-11
CH695416A5 (de) 2006-05-15
IE20010782A1 (en) 2003-04-16
GB0304150D0 (en) 2003-03-26
ZA200300284B (en) 2004-03-10
KR100880056B1 (ko) 2009-01-22
HUP0300876A2 (hu) 2003-10-28
HK1056828A1 (en) 2004-03-05
CN100350905C (zh) 2007-11-28
SE527137C2 (sv) 2005-12-27
US20030187069A1 (en) 2003-10-02
SE0300535D0 (sv) 2003-02-28
DE10196483T1 (de) 2003-07-31
ES2201941A1 (es) 2004-03-16
GR1004434B (el) 2004-02-03
FR2813530A1 (fr) 2002-03-08
CN1449282A (zh) 2003-10-15
PL359807A1 (en) 2004-09-06
BE1014352A5 (fr) 2003-09-02
CA2414921C (en) 2010-02-09
GB2381455B (en) 2004-06-30
FI119840B (fi) 2009-04-15
RU2314802C2 (ru) 2008-01-20
MXPA03001830A (es) 2004-11-01
AT504040A1 (de) 2008-02-15
CA2414921A1 (en) 2002-03-07
AT504040B1 (de) 2008-07-15
TWI290464B (en) 2007-12-01
DE10196483B4 (de) 2023-08-24
CZ2003574A3 (cs) 2003-06-18
DK200300274A (da) 2003-02-24
ITMI20011820A0 (it) 2001-08-28
NL1018862C2 (nl) 2002-03-05
FI20030276A7 (fi) 2003-02-25
HU230783B1 (hu) 2018-05-02
CZ303849B6 (cs) 2013-05-29
LU91009B1 (de) 2003-02-19
HUP0300876A3 (en) 2009-08-28
AU2001287706B2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
FR2806918B1 (fr) Catheter pour l'administration specifique d'un medicament
EP1346724A4 (en) AGENT FOR TREATING HEPATITIS C
FR2804959B1 (fr) Utilisation de derives de paullones pour la fabrication de medicaments
EP1303271A4 (en) Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
EP1028710A4 (en) TOPICAL AGENTS FOR THE ADMINISTRATION OF NON-TEROIDAL ANTI-INFLAMMATORY ACTIVE SUBSTANCES
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
FI973868A7 (fi) D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyper paratyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa
MA25842A1 (fr) Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.
EP1311261A4 (en) MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF ILLNESSES
EP0686395A3 (en) Use of hyaluronic acid in the manufacture of a medicament for inhibiting platelet aggregation
EP1293131A4 (en) MEANS FOR CLEANING TREATMENT
EP1448193A4 (en) THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEAMIC CONDITIONS
ITMI20001827A0 (it) Medicamento antinfiammatorio
FR2813530B1 (fr) Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
FR2810547B1 (fr) Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
ITMI20001216A0 (it) Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica
FR2686251B1 (fr) Composition pour la cicatrisation d'une plaie.
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
FR2818150B1 (fr) Composition pour le traitement d'objets destines a etre desinfectes
FR2816214B1 (fr) Utilisation d'un compose antagoniste de la proteine esm-1 pour la fabrication d'un medicament pour la prevention et/ou le traitement d'un cancer
FR2826278B1 (fr) Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

ST Notification of lapse

Effective date: 20200406